ID

13508

Beschrijving

Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible (PAZOPANIB-AML) https://clinicaltrials.gov/ct2/show/NCT01361334 Principal Investigator: PD Dr. Torsten Kessler, University Hospital Muenster, Germany

Link

https://clinicaltrials.gov/ct2/show/NCT01361334

Trefwoorden

Versies (3)
  1. 14-08-15 14-08-15 - Martin Dugas
  2. 06-01-16 06-01-16 -
  3. 11-02-16 11-02-16 -
Geüploaded op

11 februari 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

End of study AML Pazopanib NCT01361334

Duits Engels

End of study AML Pazopanib NCT01361334

1 Formulieren  
End of Study
Beschrijving

End of Study

Alias
UMLS CUI-1
C1518546
Patient ID (derived)
Beschrijving

Patient ID (derived)

Datatype

text

Alias
UMLS CUI [1]
C2348585
End of study: date
Beschrijving

Studienabbruch: Datum

Datatype

date

Alias
UMLS CUI [1]
C2985813
End of study: date of status
Beschrijving

Studienabbruch: Datum Status

Datatype

text

Alias
UMLS CUI [1]
C2985875
End of study: withdrawal of informed consent
Beschrijving

Studienabbruch: Widerruf der Einwilligung

Datatype

text

Alias
UMLS CUI [1]
C0021430
End of study: Violation of eligibility criteria
Beschrijving

Studienabbruch: Verletzte Ein-Ausschlusskrit.

Datatype

text

Alias
UMLS CUI [1]
C1516637
End of study: adverse event
Beschrijving

Adverse event

Datatype

text

Alias
UMLS CUI [1]
C0877248
Death
Beschrijving

Death

Datatype

text

Alias
UMLS CUI [1]
C0011065
End of study: lost to follow up
Beschrijving

Studienabbruch: Lost to follow up

Datatype

text

Alias
UMLS CUI [1]
C1302313
End of study: progressive disease
Beschrijving

Studienabbruch: Progression

Datatype

text

Alias
UMLS CUI [1]
C1335499
End of study: relapse
Beschrijving

Studienabbruch: Rezidiv

Datatype

text

Alias
UMLS CUI [1]
C0035020
End of study: new anti-leukemic treatment date
Beschrijving

Studienabbruch: Neue anti-leuk Ther - Datum

Datatype

date

Alias
UMLS CUI [1,1]
C1299575
UMLS CUI [1,2]
C0011008
End of study: new anti-leukemic treatment date status
Beschrijving

Studienabbruch: Neue anti-leuk Ther - Datum Status

Datatype

text

End of study: treatment modification, new antileukemic treatment
Beschrijving

Studienabbruch: Neue anti-leukäm. Therapie - Text

Datatype

text

Alias
UMLS CUI [1]
C1299575
End of study: other reason
Beschrijving

Studienabbruch: Anderer Gund

Datatype

text

Alias
UMLS CUI [1]
C0205394
End of study: other reason - text
Beschrijving

Studienabbruch: Anderer Gund - Text

Datatype

text

End of study: complete remission
Beschrijving

Studienabbruch: Komplette Remission (CR)

Datatype

text

Alias
UMLS CUI [1]
C0677874
End of study: CR(p)
Beschrijving

Studienabbruch: Komplette Remission (CRp)

Datatype

text

Alias
UMLS CUI [1]
C3890735
End of study: CR(i)
Beschrijving

Studienabbruch: Komplette Remission (CRi)

Datatype

text

Alias
UMLS CUI [1]
C3538993
End of study: PR
Beschrijving

Studienabbruch: Partielle Remission (PR)

Datatype

text

Alias
UMLS CUI [1]
C1521726
End of study: Stable disease
Beschrijving

Studienabbruch: Stabile Erkrankung

Datatype

text

Alias
UMLS CUI [1]
C0677946
End of study: progressive disease
Beschrijving

Studienabbruch: Progression

Datatype

text

Alias
UMLS CUI [1]
C1335499
End of study: relapse
Beschrijving

Studienabbruch: Rezidiv

Datatype

text

Alias
UMLS CUI [1]
C0035020
End of study: reason unknown
Beschrijving

Studienabbruch: Unbekannt

Datatype

text

Alias
UMLS CUI [1]
C0439673
End of study: other
Beschrijving

Studienabbruch: Sonstiges

Datatype

text

Alias
UMLS CUI [1]
C0205394
End of study: other (Text)
Beschrijving

Studienabbruch: Sonstiges - Text

Datatype

text

End of study: signature date
Beschrijving

Studienabbruch: Signatur - Datum

Datatype

date

Alias
UMLS CUI [1]
C0807937
End of study: signature - date status
Beschrijving

Studienabbruch: Signatur - Datum Status

Datatype

text

Alias
UMLS CUI [1]
C2985875
End of study: signature of investigator
Beschrijving

Studienabbruch: Signatur - Prüfer

Datatype

text

Alias
UMLS CUI [1]
C2346576
End of study: comment
Beschrijving

Kommentar Studienabbruch

Datatype

text

Alias
UMLS CUI [1]
C0947611
End of study: violated inclusion/exclusion criteria
Beschrijving

End of study: violated inclusion/exclusion criteria

Alias
UMLS CUI-1
C1518546
UMLS CUI-2
C1516637
End of study: violated inclusion/exclusion criteria Code
Beschrijving

Studienabbruch: Verletzte Ein-Ausschlusskrit. Code

Datatype

text

Alias
UMLS CUI [1,1]
C1518546
UMLS CUI [1,2]
C1516637
End of study: adverse event(s)
Beschrijving

End of study: adverse event(s)

Alias
UMLS CUI-1
C1518546
UMLS CUI-2
C0877248
End of study: adverse event(s) Nr
Beschrijving

Studienabbruch: Unerwünschte(s) Ereignis(se)-AE-Nr

Datatype

integer

Alias
UMLS CUI [1,1]
C1518546
UMLS CUI [1,2]
C0877248
Terug naar het begin van de pagina

Similar models

End of study AML Pazopanib NCT01361334

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
End of Study
C1518546 (UMLS CUI-1)
Patient ID (derived)
Item
Patient ID (derived)
text
C2348585 (UMLS CUI [1])
Studienabbruch: Datum
Item
End of study: date
date
C2985813 (UMLS CUI [1])
Item
End of study: date of status
text
C2985875 (UMLS CUI [1])
Studienabbruch: Datum Status
Code List
End of study: date of status
CL Item
T (1)
CL Item
TM (2)
CL Item
M (3)
Item
End of study: withdrawal of informed consent
text
C0021430 (UMLS CUI [1])
Studienabbruch: Widerruf der Einwilligung
Code List
End of study: withdrawal of informed consent
CL Item
End of study: withdrawal of informed consent through patient of legal representative (1)
Item
End of study: Violation of eligibility criteria
text
C1516637 (UMLS CUI [1])
Studienabbruch: Verletzte Ein-Ausschlusskrit.
Code List
End of study: Violation of eligibility criteria
CL Item
nachträgliche Feststellung durch den Prüfarzt, dass Einschlusskriterien nicht erfüllt sind ... (1)
Item
End of study: adverse event
text
C0877248 (UMLS CUI [1])
Studienabbruch: Unerwünschte(s) Ereignis(se)
Code List
End of study: adverse event
CL Item
adverse event(s) (1)
Item
Death
text
C0011065 (UMLS CUI [1])
Studienabbruch: Tod
Code List
Death
CL Item
Death (1)
Item
End of study: lost to follow up
text
C1302313 (UMLS CUI [1])
Studienabbruch: Lost to follow up
Code List
End of study: lost to follow up
CL Item
lost to follow up (1)
Item
End of study: progressive disease
text
C1335499 (UMLS CUI [1])
Studienabbruch: Progression
Code List
End of study: progressive disease
CL Item
progressive disease (1)
Item
End of study: relapse
text
C0035020 (UMLS CUI [1])
Studienabbruch: Rezidiv
Code List
End of study: relapse
CL Item
relapse (1)
Studienabbruch: Neue anti-leuk Ther - Datum
Item
End of study: new anti-leukemic treatment date
date
C1299575 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
End of study: new anti-leukemic treatment date status
text
Studienabbruch: Neue anti-leuk Ther - Datum Status
Code List
End of study: new anti-leukemic treatment date status
CL Item
T (1)
CL Item
TM (2)
CL Item
M (3)
Studienabbruch: Neue anti-leukäm. Therapie - Text
Item
End of study: treatment modification, new antileukemic treatment
text
C1299575 (UMLS CUI [1])
Item
End of study: other reason
text
C0205394 (UMLS CUI [1])
Studienabbruch: Anderer Gund
Code List
End of study: other reason
CL Item
other reason (9)
Studienabbruch: Anderer Gund - Text
Item
End of study: other reason - text
text
Item
End of study: complete remission
text
C0677874 (UMLS CUI [1])
Studienabbruch: Komplette Remission (CR)
Code List
End of study: complete remission
CL Item
CR (1)
Item
End of study: CR(p)
text
C3890735 (UMLS CUI [1])
Studienabbruch: Komplette Remission (CRp)
Code List
End of study: CR(p)
CL Item
Complete remission with incomplete platelet recovery (1)
Item
End of study: CR(i)
text
C3538993 (UMLS CUI [1])
Studienabbruch: Komplette Remission (CRi)
Code List
End of study: CR(i)
CL Item
Complete response with incomplete bone marrow recovery (1)
Item
End of study: PR
text
C1521726 (UMLS CUI [1])
Studienabbruch: Partielle Remission (PR)
Code List
End of study: PR
CL Item
Partial remission (PR) (1)
Item
End of study: Stable disease
text
C0677946 (UMLS CUI [1])
Studienabbruch: Stabile Erkrankung
Code List
End of study: Stable disease
CL Item
Stable disease (1)
Item
End of study: progressive disease
text
C1335499 (UMLS CUI [1])
Studienabbruch: Progression
Code List
End of study: progressive disease
CL Item
Progression (1)
Item
End of study: relapse
text
C0035020 (UMLS CUI [1])
Studienabbruch: Rezidiv
Code List
End of study: relapse
CL Item
relapse (1)
Item
End of study: reason unknown
text
C0439673 (UMLS CUI [1])
Studienabbruch: Unbekannt
Code List
End of study: reason unknown
CL Item
unknown (9)
Item
End of study: other
text
C0205394 (UMLS CUI [1])
Studienabbruch: Sonstiges
Code List
End of study: other
CL Item
other (9)
Studienabbruch: Sonstiges - Text
Item
End of study: other (Text)
text
Studienabbruch: Signatur - Datum
Item
End of study: signature date
date
C0807937 (UMLS CUI [1])
Item
End of study: signature - date status
text
C2985875 (UMLS CUI [1])
Studienabbruch: Signatur - Datum Status
Code List
End of study: signature - date status
CL Item
T (1)
CL Item
TM (2)
CL Item
M (3)
Item
End of study: signature of investigator
text
C2346576 (UMLS CUI [1])
Studienabbruch: Signatur - Prüfer
Code List
End of study: signature of investigator
CL Item
yes (1)
CL Item
no (0)
Kommentar Studienabbruch
Item
End of study: comment
text
C0947611 (UMLS CUI [1])
Item Group
End of study: violated inclusion/exclusion criteria
C1518546 (UMLS CUI-1)
C1516637 (UMLS CUI-2)
Item
End of study: violated inclusion/exclusion criteria Code
text
C1518546 (UMLS CUI [1,1])
C1516637 (UMLS CUI [1,2])
Studienabbruch: Verletzte Ein-Ausschlusskrit. Code
Code List
End of study: violated inclusion/exclusion criteria Code
CL Item
EIN01 (1)
CL Item
EIN02 (2)
CL Item
EIN03 (3)
CL Item
EIN04 (4)
CL Item
EIN05 (5)
CL Item
EIN06 (6)
CL Item
EIN07 (7)
CL Item
EIN08 (8)
CL Item
EIN09 (9)
CL Item
AUS01 (10)
CL Item
AUS02 (11)
CL Item
AUS03 (12)
CL Item
AUS04 (13)
CL Item
AUS05 (14)
CL Item
AUS06 (15)
CL Item
AUS07 (16)
CL Item
AUS08 (17)
CL Item
AUS09 (18)
CL Item
AUS10 (19)
CL Item
AUS11 (20)
CL Item
AUS12 (21)
CL Item
AUS13 (22)
CL Item
AUS14 (23)
CL Item
AUS15 (24)
Item Group
End of study: adverse event(s)
C1518546 (UMLS CUI-1)
C0877248 (UMLS CUI-2)
Studienabbruch: Unerwünschte(s) Ereignis(se)-AE-Nr
Item
End of study: adverse event(s) Nr
integer
C1518546 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial